J 2025

Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

KALAMEN, Kristián; František POLLÁK; Roman VAVREK; Petra PÁRTLOVÁ; Mónica GARCÍA-MELÓN et al.

Základní údaje

Originální název

Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

Autoři

KALAMEN, Kristián; František POLLÁK; Roman VAVREK; Petra PÁRTLOVÁ a Mónica GARCÍA-MELÓN

Vydání

Polish Journal of Management Studies, 2025, 2081-7452

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

50200 5.2 Economics and Business

Stát vydavatele

Polsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.100 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/75081431:_____/25:00002897

Organizační jednotka

Vysoká škola technická a ekonomická v Českých Budějovicích

Klíčová slova anglicky

pharmaceutical sector; covid-19; stock market volatility; investment risk; financial resilience

Štítky

Změněno: 25. 7. 2025 07:41, Ing. Barbora Langšádlová

Anotace

V originále

This study aims to analyze the financial impact of the COVID-19 pandemic on the pharmaceutical sector by assessing market volatility, stock performance, and investment behavior across different pandemic waves. It provides a novel perspective by examining the different financial responses of major pharmaceutical companies, Johnson and Johnson, Pfizer, and Moderna, over 949 trading days (March 2019-December 2022). Using statistical tools such as standard deviation and kurtosis, the study identifies volatility patterns and extreme price movements before, during, and after the pandemic. The results show that the first and fourth waves had the highest market volatility, influenced by vaccine development, regulatory decisions and changing investor sentiment. While short-term financial gains were significant, long-term profitability was challenged by market corrections and policy constraints. This study contributes to the literature by providing insights into crisis-driven financial instability and highlights the need for risk aware investment strategies in the pharmaceutical sector.

Přiložené soubory

separat_-_Pollak__Partlova__IDUPS25005.pdf
Požádat o autorskou verzi souboru